Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 26, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals,
Inc., (Nasdaq:IDIX) announced today that Idenix management will present a
corporate overview at the Cowen and Company 33rd Annual Health Care Conference
on March 4, 2013 at 2:50 p.m. ET at the Boston Marriott Copley Place and at
the Barclays Global Healthcare Conference on March 13, 2013 at 3:15 p.m. ET at
the Loews Miami Hotel.

The live and archived webcasts of the company presentations can be accessed
under "Events and Presentations" in the Idenix Investor Center at Please log in approximately 5-10 minutes before each event to
ensure a timely connection. The archived replay will be available on the
Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development of drugs
for the treatment of human viral diseases. Idenix's current focus is on the
treatment of patients with chronic hepatitis C infection. For further
information about Idenix, please refer to

CONTACT: Idenix Pharmaceuticals Contacts:
         Kelly Barry (617) 995-9033  (media)
         Teri Dahlman (617) 995-9807 (investors)
Press spacebar to pause and continue. Press esc to stop.